[
  {
    "ts": null,
    "headline": "Is ResMed's 10% Year-to-Date Gain Justified After Recent Industry Headlines?",
    "summary": "Ever wondered if ResMed stock is actually a steal or quietly overhyped? You're not alone. This article will dig beneath the surface to find out. Shares have seen modest gains recently, with the price up 2.6% over the past week and nearly 10% year-to-date. However, the last month saw a slight decline of 5.9%. Several headlines have been swirling around ResMed, from industry-wide updates in digital health and respiratory care to regulatory news shaping the medical device market. These stories...",
    "url": "https://finnhub.io/api/news?id=7b2167abe73a58add55d2e7938fe60aab21d3b869c3814e47a2732c7f6445edf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763849587,
      "headline": "Is ResMed's 10% Year-to-Date Gain Justified After Recent Industry Headlines?",
      "id": 137586995,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Ever wondered if ResMed stock is actually a steal or quietly overhyped? You're not alone. This article will dig beneath the surface to find out. Shares have seen modest gains recently, with the price up 2.6% over the past week and nearly 10% year-to-date. However, the last month saw a slight decline of 5.9%. Several headlines have been swirling around ResMed, from industry-wide updates in digital health and respiratory care to regulatory news shaping the medical device market. These stories...",
      "url": "https://finnhub.io/api/news?id=7b2167abe73a58add55d2e7938fe60aab21d3b869c3814e47a2732c7f6445edf"
    }
  }
]